Vita Life Sciences (VLS) Stock Price, News & Analysis

Company Overview

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritionals; urinary health; weight management; immunity; skin, hair, and nails; liver and digestion; fertility, pregnancy, and postpartum; blood sugar management; cardiovascular health; pain and inflammation; men, women, and children's health; antioxidants; bones, joints, and muscles; and eye health. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 2,815 shs
• Average Volume: N/A
• Market Capitalization: $107.10 million
• P/E Ratio: 11.27
• Dividend Yield: 4.94%
• Price Target: N/A
• Consensus Rating: N/A

VLS Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of Vita Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vita Life Sciences investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU) and VelocityShares 1x Long VSTOXX Futures ETN (EVIX).

Company Calendar

• Ex-Dividend for 4/10 Dividend: 3/20/2025
• Today: 3/26/2025
• Dividend Payable: 4/10/2025

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: ASX:VLS
• CIK: N/A
• Web: www.vitalifesciences.com
• Phone: 61 3 9828 0500
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A$0.17
• Trailing P/E Ratio: 11.27
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $9.39 million
• Net Margins: 11.90%
• Pretax Margin: N/A
• Return on Equity: 20.38%
• Return on Assets: 12.37%

Debt

• Debt-to-Equity Ratio: 0.88
• Current Ratio: 2.96
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $79.17 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.62
• Book Value: A$0.89 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 56,400,000
• Free Float: N/A
• Market Cap: $107.10 million
• Optionable: Not Optionable
• Beta: 0.46